Error loading player: No playable sources found
AM24-MN-05-O
AM24-MN-05-O: Donor and Recipient Safety and Transfusion Efficacy Research: Past, Present and Future (presented by Michael Busch, Landsteiner-Alter Award recipient) (Enduring)
Date
October 23, 2024
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP) | 1 Physician (PHY)
$30
Standard Price
Members save $5
Award Citation: In recognition of his critical, field-advancing research throughout his extraordinary career. Among Dr. Busch’s many accomplishments, his work has been vital in improving our understanding of viral and serological markers, as well as the infectivity of blood transfusions. His research played a significant role in helping the field to further develop strategies to reduce the risk of transfusion-transmitted infections, thus improving the safety of blood transfusion and biotherapies worldwide.
Learning Objectives
- Describe how large studies of blood donors and recipients have evolved over the past 40 years to quantify and reduce risks of transfusion-transmitted infections and to respond to emerging infectious diseases that may be threats to blood safety
- Explain how “big-data” studies using blood donor samples are contributing to public health surveillance and epidemiologic insights into infectious diseases
- Illustrate how U.S. and international studies of donor-recipient vein-to-vein databases with linkage to repositories and disease registries are advancing the goal of Precision Transfusion Medicine" Michael P. Busch, MD, PhD
Moderator
Aaron A. Tobian, PhD, MD
Department of Pathology, Johns Hopkins University School of Medicine
Award Presenter
Speaker
Tracks
Related Products
AM24-MN-43-O: Trans, Non-binary, and Gender-Diverse Peoples: How You Can Make a Difference for Donors, Patients, and Communities (Enduring)
Many blood operators around the world are implementing individualized donor assessments that welcome more trans, non-binary, and gender-diverse people to donate…
AM24-ST-18-O: AABB RBC and Platelet International Guidelines: What is New: Liberally Restrictive and Restrictively Liberal? (Enduring)
The AABB continues to update and develop clinical transfusion guidelines as new evidence becomes available…
AM24-MN-36-O: From Courts to Congress: Navigating the Healthcare Policy Landscape in 2024 (Enduring)
In today’s rapidly evolving healthcare environment, understanding the latest policy developments is crucial for strategic planning and operational success. This session will explore the significant implications of the recent Supreme Court decision – Loper Bright Enterprises v…
AM24-SN-14-O: Blood Donation, Race and Transfusion Medicine: Looking Back to Move Forward (Enduring)
Race is a sociopolitical and not biological construct. As such, the use of race-based algorithms and disease associations has caused demonstrable harm such as delayed kidney transplant referral and missed diagnoses. The field of transfusion medicine is not immune…
